Takeda is a global biopharmaceutical company with a patient-focused, values-based, research and development-driven approach aiming to bring Better Health and a Brighter Future to people worldwide, underpinned by more than 230 years of history in Japan. The company is dedicated to supporting communities through corporate giving, employee volunteerism, and employee giving, particularly within the U.S., to foster impactful relationships and contributions.
Takeda Oncology Education Grants are designed to support a variety of programs that align with Takeda's goal to help people living with cancer achieve optimal health outcomes. The grants focus on education for healthcare providers and patients, support for independent scientific research, sponsorships, and charitable contributions. While Takeda reviews grant requests across multiple disease areas, priority is given to programs related to Hematology (Multiple Myeloma, Lymphoma, and Leukemia) and Solid Tumors (Lung cancer and previously treated metastatic colorectal cancer).